Cargando…
Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome
Globally, a shift in the epidemiology of chronic liver disease has been observed. This has been mainly driven by a marked decline in the prevalence of chronic hepatitis B virus infection (CHB), with the greatest burden restricted to the Western Pacific and sub-Saharan African regions. Amidst this is...
Autores principales: | Amponsah-Dacosta, Edina, Tamandjou Tchuem, Cynthia, Anderson, Motswedi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747023/ https://www.ncbi.nlm.nih.gov/pubmed/33362998 http://dx.doi.org/10.5501/wjv.v9.i5.54 |
Ejemplares similares
-
Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
por: Amponsah-Dacosta, Edina
Publicado: (2021) -
Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019) -
Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults
por: Laiwatthanapaisan, Ratchapong, et al.
Publicado: (2021) -
Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022) -
Joint replacement and human immunodeficiency virus
por: Salimi, Maryam, et al.
Publicado: (2023)